Impact of Patent Expirations on API Demand
Patent expirations for blockbuster drugs create significant opportunities for the Active Pharmaceutical Ingredients Market, as generic manufacturers rush to capture market share. This increases demand for cost-effective, high-quality APIs that can be rapidly scaled to meet post-patent demand surges.
API producers that can quickly ramp up production while maintaining strict compliance with regulatory requirements are best positioned to benefit. The generics boom, however, also leads to pricing pressures, requiring manufacturers to maintain efficiency and explore value-added services to protect margins.
Moreover, the shift toward biosimilar APIs following biologic patent expirations presents both technical challenges and lucrative growth prospects, as these molecules demand specialized expertise and facilities.